Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Tirzepatide sold as Zepbound for weight management and Mounjaro for type 2 diabetes is a once-weekly injectable medication that activates both GLP-1 and GIP receptors to support meaningful appetite control and weight loss
Get a baseline scan before or early in your GLP-1 therapy, then retest every 3-4 months
Jorgensen says weight loss is an issue she and her family members have struggled with, and when they heard about GLP-1 products, they wanted to make them available locally
Moreover, expanding indications aims to explore new markets
US$ 22.07
US$ 24.55
US$ 24.86
:quality(75):max_bytes(102400)/https://assets.iprofesional.com/assets/jpg/2025/12/608599.jpg)
US$ 24.54
